{"id":"NCT01397461","sponsor":"Ferrer Internacional S.A.","briefTitle":"Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo","officialTitle":"A Phase III 3 Arms, Multicenter, Randomised, Investigator-blind Study to Assess the Efficacy and Safety of Ozenoxacin 1% Cream Applied Twice Daily for 5 Days Versus Placebo in the Treatment of Patients With Impetigo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2011-07-19","resultsPosted":"2016-05-18","lastUpdate":"2016-07-01"},"enrollment":465,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Impetigo"],"interventions":[{"type":"DRUG","name":"ozenoxacin placebo","otherNames":[]},{"type":"DRUG","name":"retapamulin 1% ointment","otherNames":[]},{"type":"DRUG","name":"ozenoxacin 1% cream","otherNames":[]}],"arms":[{"label":"ozenoxacin 1% cream","type":"EXPERIMENTAL"},{"label":"ozenoxacin placebo","type":"PLACEBO_COMPARATOR"},{"label":"retapamulin 1% ointment","type":"ACTIVE_COMPARATOR"}],"summary":"This is multicenter, randomised, placebo controlled, parallel, blinded (double-blind for ozenoxacin versus placebo comparison and investigator blinded for retapamulin versus placebo comparison), superiority clinical study comparing ozenoxacin cream versus placebo and retapamulin ointment vs placebo, in patients with a clinical diagnosis of non-bullous or bullous impetigo.","primaryOutcome":{"measure":"Clinical Success","timeFrame":"2 weeks","effectByArm":[{"arm":"Ozenoxacin 1% Cream","deltaMin":34.8,"sd":null},{"arm":"Ozenoxacin Placebo","deltaMin":19.2,"sd":null},{"arm":"Retapamulin 1% Ointment","deltaMin":37.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.003"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":19,"countries":["Germany","South Africa"]},"refs":{"pmids":["30365584"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":156},"commonTop":[]}}